2024-11-20 08:35:10
Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development
Corporate/ 2023-07-24
Clinical Study Collaborator HCL Sends Fi...

VANCOUVER,BC,June 15,2022-- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"),an...

Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting
Corporate/ 2023-07-24
Burning Rock Presents Latest Clinical Da...

SHANGHAI,June 15,2022-- Burning Rock (NASDAQ:BNR) presented the final results from the multi-center case-control THUNDER study (THe UNintrus...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release